Literature DB >> 2157641

Human seminal plasma inhibits the lymphocyte response to infection with Epstein-Barr virus.

M J Turner1, J O White, W P Soutter.   

Abstract

Epidemiological studies have shown that infection by the Epstein-Barr virus (EBV) is most common in the age group in which sexual activity commences. This observation and the recent evidence that EBV replication can occur in the epithelium of the uterine cervix have led to the suggestion that EBV may be sexually transmitted. Activation of cytotoxic T lymphocytes is important in the control of EBV replication. Using an established lymphocyte regression assay, this study showed that dialyzed human seminal plasma in low concentrations inhibits the normal lymphocyte response to infection with EBV. These results suggest that seminal plasma may facilitate EBV replication in the uterine cervix by inhibition of lymphocyte function. This effect may also be important in the host response to other sexually transmitted viruses and may have some bearing on the etiology of cervical cancer.

Entities:  

Mesh:

Year:  1990        PMID: 2157641     DOI: 10.1016/0090-8258(90)90309-9

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  4 in total

1.  The genesis of cervical cancer.

Authors:  M J Turner
Journal:  Ir J Med Sci       Date:  1990-04       Impact factor: 1.568

Review 2.  Viruses in the mammalian male genital tract and their effects on the reproductive system.

Authors:  N Dejucq; B Jégou
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

Review 3.  Semen alloantigens and lymphocytotoxic antibodies in AIDS and ICL.

Authors:  R S Root-Bernstein; S H DeWitt
Journal:  Genetica       Date:  1995       Impact factor: 1.082

4.  Co-existing of HSV1/2 or EBV Infection with the Presence of High-Risk HPV DNA in Cervical Lesions in the Southwest of Iran.

Authors:  Negar Joharinia; Sajad Faghihinejad; Keyvan Seyedi; Ali Farhadi; Seyed Younes Hosseini; Akbar Safaei; Helen Bahrampour; Jamal Sarvari
Journal:  Asian Pac J Cancer Prev       Date:  2020-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.